LuxNet Corporation (TPEX:4979)

Sage Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,110	3,128	1,832	483.83	368.73	292.32
Cash & Short-Term Investments	3,110	3,128	1,832	483.83	368.73	292.32
Cash Growth	46.81%	70.70%	278.70%	31.22%	26.14%	-46.31%
Accounts Receivable	456.73	400.42	300.47	254.4	131.63	144.07
Other Receivables	29.07	46.6	26.38	14.23	6.23	-
Receivables	485.8	447.02	326.85	268.63	137.86	144.07
Inventory	414.95	386.07	561.85	473.88	292.31	311.37
Prepaid Expenses	7.53	3.46	3.55	3.2	2.92	10.14
Other Current Assets	8.02	7.11	2.36	7.5	3.06	8.87
Total Current Assets	4,026	3,971	2,727	1,237	804.87	766.76
Property, Plant & Equipment	909.84	615.16	654.26	706.07	824.59	1,021
Long-Term Investments	46.73	86.78	131.84	126.35	317.11	354.57
Other Intangible Assets	0.89	1.17	0.87	0.62	0.52	0.51
Other Long-Term Assets	48.52	70.67	6.23	2.49	1.9	27.63
Total Assets	5,032	4,745	3,520	2,073	1,949	2,170
Accounts Payable	436.8	451.63	362.42	302.12	130.47	110.3
Accrued Expenses	-	132.3	111.64	72.61	60.59	-
Short-Term Debt	-	-	-	52.82	88.15	235.35
Current Portion of Long-Term Debt	-	-	-	-	-	12.26
Current Income Taxes Payable	2.05	6.39	-	-	-	-
Current Unearned Revenue	0.39	0.47	6.26	2.87	6.57	0.1
Other Current Liabilities	390.49	10.17	3.78	5.11	6.7	101.84
Total Current Liabilities	829.73	600.95	484.09	435.53	292.48	459.85
Long-Term Debt	752.55	743.09	-	220	320	320
Other Long-Term Liabilities	1.32	3	-	-	-	-
Total Liabilities	1,584	1,347	484.09	655.53	612.48	780.13
Common Stock	1,408	1,408	1,408	1,324	1,325	1,201
Additional Paid-In Capital	1,174	1,174	1,099	4.15	128.39	85.81
Retained Earnings	906	875.14	543.04	109.43	-285.2	-87.45
Comprehensive Income & Other	-40.05	-59.66	-14.6	-20.13	168.2	190.76
Shareholders' Equity	3,449	3,398	3,036	1,417	1,337	1,390
Total Liabilities & Equity	5,032	4,745	3,520	2,073	1,949	2,170
Total Debt	752.55	743.09	-	272.82	408.15	567.61
Net Cash (Debt)	2,357	2,385	1,832	211.01	-39.43	-275.29
Net Cash Growth	11.29%	30.15%	768.35%	-	-	-
Net Cash Per Share	16.63	16.93	13.81	1.59	-0.31	-2.34
Filing Date Shares Outstanding	141.22	140.84	140.84	132.36	132.51	120.13
Total Common Shares Outstanding	141.22	140.84	140.84	132.36	132.51	120.13
Working Capital	3,196	3,370	2,243	801.49	512.39	306.91
Book Value Per Share	24.42	24.13	21.56	10.71	10.09	11.57
Tangible Book Value	3,448	3,397	3,035	1,416	1,336	1,390
Tangible Book Value Per Share	24.41	24.12	21.55	10.70	10.08	11.57
Land	-	247.7	247.7	247.7	247.7	247.7
Buildings	-	367.28	362.78	362.78	362.78	361.78
Machinery	-	1,353	1,400	1,362	1,363	1,504

Source: S&P Global Market Intelligence. Standard template. Financial Sources.